Notable Labs, Ltd. (NTBL)
NASDAQ: NTBL · IEX Real-Time Price · USD
0.710
-0.010 (-1.39%)
Jul 22, 2024, 10:00 AM EDT - Market open
Notable Labs Employees
Notable Labs had 16 employees as of December 31, 2023.
Employees
16
Change
n/a
Growth
n/a
Revenue / Employee
$19,438
Profits / Employee
-$763,500
Market Cap
6.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 16 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| XWELL | 337 |
| Sunshine Biopharma | 44 |
| Pulmatrix | 22 |
| GlucoTrack | 6 |
| Tenax Therapeutics | 6 |
| Virios Therapeutics | 4 |
| Cadrenal Therapeutics | 4 |
| Alaunos Therapeutics | 1 |
NTBL News
- 2 months ago - Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024 - GlobeNewsWire
- 3 months ago - Notable Labs Reports 2023 Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024 - GlobeNewsWire
- 3 months ago - Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform - GlobeNewsWire
- 4 months ago - Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform - GlobeNewsWire
- 5 months ago - Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment - GlobeNewsWire
- 7 months ago - Notable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial Outcome - GlobeNewsWire
- 7 months ago - Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes - PRNewsWire